Lepik K, Mikhailova N, Kondakova E, et al. Nivolumab for treatment of patients with relapsed/refractory classical Hodgkin’s lymphoma (CHL): clinical and patient-reported outcomes. 24th Congress of EHA, abstract PS1239.
Met overnames hoopt Galapagos toegang tot CAR T-celtherapie te versnellen
jul 2022 | Leukemie, Lymfoom